These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3261812)

  • 1. [Increase in the activated (HLA-DR+) T-cells in the peripheral blood lymphocyte of patients with alopecia areata].
    Imai R; Miura J; Numata K; Aikawa Y; Takamori K; Ogawa H
    Nihon Hifuka Gakkai Zasshi; 1988 Mar; 98(3):355-60. PubMed ID: 3261812
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of HLA-DR+ T cells and natural killer (NK) cells in the peripheral blood lymphocytes of alopecia areata (AA)].
    Imai R
    Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1143-52. PubMed ID: 2273577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
    Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
    J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of activated T cells and natural killer (NK) cells with the disease activity of alopecia areata (AA)].
    Imai R; Miura J; Takamori K
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):743-5. PubMed ID: 2585776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased HLA-DR+ T-lymphocyte population in peripheral blood of alopecia areata.
    Imai R; Miura J; Takamori K; Ogawa H
    Clin Exp Dermatol; 1991 May; 16(3):176-80. PubMed ID: 1934567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata.
    Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
    Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
    J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HLA-DR antigens and alopecia areata].
    Offidani AM; Simonetti O; Politi A; Salvi A; Gabrielli A; Bossi G
    G Ital Dermatol Venereol; 1988 Sep; 123(9):409-12. PubMed ID: 3243579
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of peripheral T-cell subpopulations and lymphocyte proliferation in different phases of evolution of alopecia areata.
    Mak CP; Wu YC; Chang CH; Hsieh RP; Lü YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 May; 20(2):95-103. PubMed ID: 3498608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis.
    Baker BS; Powles A; Garioch JJ; Hardman C; Fry L
    Br J Dermatol; 1997 Mar; 136(3):319-25. PubMed ID: 9115908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Selective changes in lymphocytic differentiation antigens in the peripheral blood of patients with alopecia areata treated with oral zinc].
    Lutz G; Kreysel HW
    Z Hautkr; 1990 Feb; 65(2):132-4, 137-8. PubMed ID: 1971470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphocyte subpopulations in alopecia areata].
    Calandria L; Paciel J; Bruno J; Martini M; Vignale R; Civila E
    Med Cutan Ibero Lat Am; 1986; 14(3):163-5. PubMed ID: 3526043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance.
    Duvic M; Hordinsky MK; Fiedler VC; O'Brien WR; Young R; Reveille JD
    Arch Dermatol; 1991 Jan; 127(1):64-8. PubMed ID: 1670917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood lymphocyte subpopulations and antibody dependent, cell-mediated cytotoxicity (ADCC) in alopecia areata and universalis.
    Gu SQ; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1981; 61(2):125-9. PubMed ID: 6165187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in populations of HLA-DR+CD3+ cells and CD57-CD16+ cells in alopecia areata after corticosteroid therapy.
    Imai R; Takamori K; Ogawa H
    Dermatology; 1994; 188(2):103-7. PubMed ID: 7511010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
    Sato-Kawamura M; Aiba S; Tagami H
    Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alopecia areata. Causes and possibilities of therapy].
    Hamm H
    Med Monatsschr Pharm; 1991 Jan; 14(1):2-4. PubMed ID: 2017107
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased in vitro lymphocyte stimulation and reduced sensitivity to IL-2 in patients with alopecia areata.
    Orecchia G; Capelli E; Martinetti M; Cuccia Belvedere M; Rabbiosi G
    Arch Dermatol Res; 1988; 280 Suppl():S47-50. PubMed ID: 3261574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata.
    Perret C; Wiesner-Menzel L; Happle R
    Acta Derm Venereol; 1984; 64(1):26-30. PubMed ID: 6203277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increase of circulating HLA DR+ T lymphocytes in psoriasis].
    Paciel J; Vignale RA; Bruno J; Vázquez G; De Anda G
    Med Cutan Ibero Lat Am; 1984; 12(6):497-500. PubMed ID: 6397671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.